Institute for Safe Medication Practices
Coverage of Institute for Safe Medication Practices in the Nexus archive.
- RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists
A federal health advisory panel narrowly recommended easing FDA restrictions on peptides like BPC-157 and TB-500, despite objections from FDA scientists citing insufficient safety and efficacy data. The decision, with an 8-6 vote, could boost telehealth marketing of these substances for wellness uses, though the FDA is not obligated to follow the panel's advice.
- FDA reviews peptide injections favored by RFK Jr. and wellness influencers
The FDA is reviewing several peptides popularized by RFK Jr. and wellness influencers, despite limited evidence of their safety or effectiveness. The agency's advisers include industry-linked experts, while FDA scientists argue more data is needed before allowing broader access.
- FDA reviews peptide injections favored by RFK Jr. and wellness influencers
The FDA is reviewing peptides popularized by RFK Jr. and wellness influencers like Joe Rogan and Gary Brecka, despite limited evidence of safety or effectiveness. The agency's advisory panel includes experts with financial ties to the peptide industry, raising concerns about conflicts of interest.
- FDA reviews peptide injections favored by RFK Jr. and wellness influencers
The FDA is reviewing peptides, unproven substances popularized by RFK Jr. and wellness influencers, with health advisers divided over their safety and efficacy. The meeting includes experts with financial ties to the peptide industry, raising concerns about conflicts of interest.